Amoxicillin and Clavulanate Oral Presentations Shortage
Last Updated: September 12, 2023
Status: Current
Products Affected - Description
-
- Amoxicillin and Clavulanate oral powder for suspension, Hikma, 200 mg/5 mL - 28.5 mg/5 mL, 100 mL bottle, 1 count, NDC 00143-9981-01
- Amoxicillin and Clavulanate oral powder for suspension, Hikma, 200 mg/5 mL - 28.5 mg/5 mL, 50 mL bottle, 1 count, NDC 00143-9981-50
- Amoxicillin and Clavulanate oral powder for suspension, Hikma, 200 mg/5 mL - 28.5 mg/5 mL, 75 mL bottle, 1 count, NDC 00143-9981-75
- Amoxicillin and Clavulanate oral powder for suspension, Hikma, 400 mg/5 mL - 57 mg/5 mL, 100 mL bottle, 1 count, NDC 00143-9982-01
- Amoxicillin and Clavulanate oral powder for suspension, Hikma, 400 mg/5 mL - 57 mg/5 mL, 50 mL bottle, 1 count, NDC 00143-9982-50
- Amoxicillin and Clavulanate oral powder for suspension, Hikma, 400 mg/5 mL - 57 mg/5 mL, 75 mL bottle, 1 count, NDC 00143-9982-75
- Amoxicillin and Clavulanate oral powder for suspension, Hikma, 600 mg/5 mL - 42.9 mg/5 mL, 125 mL bottle, 1 count, NDC 00143-9853-16
- Amoxicillin and Clavulanate oral powder for suspension, Hikma, 600 mg/5 mL - 42.9 mg/5 mL, 200 mL bottle, 1 count, NDC 00143-9853-24
- Amoxicillin and Clavulanate oral powder for suspension, Hikma, 600 mg/5 mL - 42.9 mg/5 mL, 75 mL bottle, 1 count, NDC 00143-9853-75
- Amoxicillin and Clavulanate oral tablet, Hikma, 875 mg/125 mg, 20 count, NDC 00143-9249-20
- Amoxicillin and Clavulanate oral extended release tablet, Sandoz, 1000 mg / 62.5 mg, 28 count, NDC 00781-1943-82
- Amoxicillin and Clavulanate oral extended release tablet, Sandoz, 1000 mg / 62.5 mg, 40 count, NDC 00781-1943-39
- Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 200 mg/5 mL - 28.5 mg/5 mL, 100 mL bottle, 1 count, NDC 00781-6102-46
- Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 200 mg/5 mL - 28.5 mg/5 mL, 50 mL bottle, 1 count, NDC 66685-1011-00
- Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 200 mg/5 mL - 28.5 mg/5 mL, 75 mL bottle, 1 count, NDC 66685-1011-01
- Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 400 mg/5 mL - 57 mg/5 mL, 100 mL bottle, 1 count, NDC 00781-6104-46
- Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 400 mg/5 mL - 57 mg/5 mL, 50 mL bottle, 1 count, NDC 66685-1012-00
- Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 400 mg/5 mL - 57 mg/5 mL, 75 mL bottle, 1 count, NDC 66685-1012-01
- Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 600 mg/5 mL - 42.9 mg/5 mL, 125 mL bottle, 1 count, NDC 00781-6139-54
- Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 600 mg/5 mL - 42.9 mg/5 mL, 200 mL bottle, 1 count, NDC 00781-6139-48
- Amoxicillin and Clavulanate oral powder for suspension, Sandoz, 600 mg/5 mL - 42.9 mg/5 mL, 75 mL bottle, 1 count, NDC 00781-6139-57
- Amoxicillin and Clavulanate oral tablet, Sandoz, 250 mg / 125 mg, 30 count, NDC 00781-1874-31
- Amoxicillin and Clavulanate oral tablet, Sandoz, 500 mg / 125 mg, 20 count, NDC 00781-1831-20
- Amoxicillin and Clavulanate oral tablet, Sandoz, 500 mg / 125 mg, 100 count, NDC 00781-1831-01
- Amoxicillin and Clavulanate oral tablet, Sandoz, 875 mg / 125 mg, 20 count, NDC 66685-1852-20
- Amoxicillin and Clavulanate oral tablet, Sandoz, 875 mg / 125 mg, 100 count, NDC 00781-1852-01
- Amoxicillin and Clavulanate oral powder for suspension, Teva, 200 mg/5 mL - 28.5 mg/5 mL, 100 mL bottle, 1 count, NDC 00093-2277-73
- Amoxicillin and Clavulanate oral powder for suspension, Teva, 400 mg/5 mL - 57 mg/5 mL, 100 mL bottle, 1 count, NDC 00093-2279-73
- Amoxicillin and Clavulanate oral powder for suspension, Teva, 600 mg/5 mL - 42.9 mg/5 mL, 125 mL bottle, 1 count, NDC 00093-8675-75
- Amoxicillin and Clavulanate oral powder for suspension, Teva, 600 mg/5 mL - 42.9 mg/5 mL, 200 mL bottle, 1 count, NDC 00093-8675-74
- Amoxicillin and Clavulanate oral powder for suspension, Teva, 600 mg/5 mL - 42.9 mg/5 mL, 75 mL bottle, 1 count, NDC 00093-8675-78
- Amoxicillin and Clavulanate oral tablet, Teva, 200 mg/28.5 mg, 20 count, NDC 00093-2270-34
- Amoxicillin and Clavulanate oral tablet, Teva, 400 mg/57 mg, 20 count, NDC 00093-2272-34
- Amoxicillin and Clavulanate oral tablet, Teva, 500 mg/125 mg, 20 count, NDC 00093-2274-34
- Amoxicillin and Clavulanate oral tablet, Teva, 875 mg/125 mg, 20 count, NDC 00093-2275-34
- Amoxicillin and Clavulanate oral powder for suspension, Wockhardt USA, 250 mg/5 mL - 62.5 mg/5 mL, 100 mL bottle, 1 count, NDC 60432-0065-00
- Amoxicillin and Clavulanate oral powder for suspension, Wockhardt USA, 250 mg/5 mL - 62.5 mg/5 mL, 150 mL bottle, 1 count, NDC 60432-0065-47
- Amoxicillin and Clavulanate oral powder for suspension, Wockhardt USA, 250 mg/5 mL - 62.5 mg/5 mL, 75 mL bottle, 1 count, NDC 60432-0065-75
Reason for the Shortage
-
- Aurobindo refuses to provide availability information.
- Hikma did not provide a reason for the shortage.
- Micro Labs was not available to provide information.
- Sandoz did not provide a reason for the shortage.
- Teva did not provide a reason for the shortage.
- US Antibiotics has amoxicillin and clavulanate oral suspension available.
- Wockhardt did not provide a reason for the shortage.
Available Products
-
- Amoxicillin and Clavulanate oral powder for suspension, US Antibiotics, 600 mg/5 mL - 42.9 mg/5 mL, 125 mL bottle, 1 count, NDC 81964-0206-69
- Amoxicillin and Clavulanate oral powder for suspension, US Antibiotics, 600 mg/5 mL - 42.9 mg/5 mL, 200 mL bottle, 1 count, NDC 81964-0203-54
- Amoxicillin and Clavulanate oral powder for suspension, US Antibiotics, 600 mg/5 mL - 42.9 mg/5 mL, 75 mL bottle, 1 count, NDC 81964-0203-51
Estimated Resupply Dates
-
- Hikma has all amoxicillin and clavulanate oral presentations on allocation.
- Sandoz has all amoxicillin and clavulanate oral presentations either on back order or in limited supply.
- Teva has all presentations on intermittent back order and the company is releasing supplies as they become available.
- Wockhardt has amoxicillin and clavulanate 250 mg/5 mL-62.5 mg/5 mL 75 mL, 100 mL, and 150 mL bottles on back order and the company cannot estimate a release date.
Updated
Updated September 12, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created November 18, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.